Zacks Investment Research upgraded shares of Olympus Corp. (OTCMKTS:OCPNY) from a hold rating to a buy rating in a research note released on Wednesday, October 18th. Zacks Investment Research currently has $40.00 price objective on the stock.
According to Zacks, “OLYMPUS CORPORATION is a Japan-based company. The Company is engaged in the manufacturing and selling of precision machineries and instruments. The businesses of the Company include Imaging System Business, Medical Systems Business, Life Science Business, Information and Communication Business, and Others Business. Olympus has always been a company that makes people’s dreams come true through innovative products. Olympus cameras have always been at the leading edge of innovation. “
Shares of Olympus Corp. (OCPNY) traded up $0.40 during mid-day trading on Wednesday, hitting $37.65. The stock had a trading volume of 3,066 shares, compared to its average volume of 13,090. The company has a current ratio of 1.78, a quick ratio of 1.28 and a debt-to-equity ratio of 0.54. Olympus Corp. has a one year low of $33.17 and a one year high of $39.49. The firm has a market cap of $5,570.00, a PE ratio of 23.43 and a beta of 1.05.
TRADEMARK VIOLATION NOTICE: This story was first posted by BBNS and is the property of of BBNS. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright law. The legal version of this story can be accessed at https://baseballnewssource.com/markets/olympus-corp-ocpny-upgraded-to-buy-by-zacks-investment-research/1723076.html.
Olympus Corp. Company Profile
Olympus Corporation is engaged in the manufacture and sale of precision machineries and instruments. The Company’s segments include Medical Business, Scientific Solutions Business, Imaging Business and Others. The Company’s Medical Business manufactures and sells medical endoscopes, surgical endoscopes, endotherapy devices and other products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Olympus Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus Corp. and related companies with our FREE daily email newsletter.